• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Real Time PCR qPCR Market

    ID: MRFR/HC/43651-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Real-Time PCR qPCR Market Research Report By Product (Reagents Consumables, Instruments, Software Services), By Application (Clinical, Research, Forensics) and By End User (Hospitals Centers, Research Laboratories Academic Institutes, Pharmaceutical Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Real Time PCR qPCR Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    UK Real Time PCR qPCR Market Summary

    The United Kingdom Real-Time PCR qPCR market is projected to grow significantly over the next decade.

    Key Market Trends & Highlights

    UK Real-Time PCR qPCR Key Trends and Highlights

    • The market valuation is expected to increase from 350 USD Million in 2024 to 750 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 7.17 percent is anticipated from 2025 to 2035.
    • The growth trajectory indicates a robust demand for Real-Time PCR qPCR technologies in various applications.
    • Growing adoption of Real-Time PCR qPCR due to advancements in diagnostic capabilities is a major market driver.

    Market Size & Forecast

    2024 Market Size 350 (USD Million)
    2035 Market Size 750 (USD Million)
    CAGR (2025-2035) 7.17%

    Major Players

    Qiagen, PerkinElmer, Promega Corporation, SYGNIS AG, Takara Bio, Thermo Fisher Scientific, Roche, Merck KGaA, Danaher Corporation, Abbott Laboratories, Agilent Technologies, F. Hoffmann-La Roche AG, BioRad Laboratories, Novo Nordisk, Illumina

    UK Real Time PCR qPCR Market Trends

    The UK Real-Time PCR qPCR market is experiencing significant growth driven by advancements in biotechnology and rising demand for rapid diagnostic tools. A key market driver is the ongoing emphasis on infectious disease testing, particularly highlighted during public health emergencies such as the COVID-19 pandemic. The UK government’s commitment to enhancing diagnostic capabilities in response to health crises has further accelerated the adoption of qPCR technologies in clinical and research settings. Opportunities in this market are plentiful, especially with the push for personalized medicine and the increasing prevalence of genetic disorders.

    There is also notable government backing for research and development in life sciences, fostering innovation and expanding the scope of qPCR applications in areas like drug development and genomics. In recent times, the trend of automation in laboratory processes has gained traction, leading to more efficient workflows and a reduction in human error. The integration of artificial intelligence to enhance data analysis and interpretation in qPCR testing is also emerging as a key trend, positioning laboratories to leverage technology effectively.

    Furthermore, the rise of point-of-care testing in the UK reflects a shift towards decentralized diagnostic solutions, making qPCR more accessible and timelier for patients across various healthcare settings. Overall, the combination of technological advancements, increased healthcare investments, and the urgent need for accurate diagnostics is shaping the UK Real-Time PCR qPCR market. With continued support from government policies and the healthcare sector, the market is poised for further expansion and innovation.

    UK Real Time PCR qPCR Market Drivers

    Market Segment Insights

    UK Real-Time PCR qPCR Market Segment Insights

    UK Real-Time PCR qPCR Market Segment Insights

    Real-Time PCR qPCR Market Product Insights

    Real-Time PCR qPCR Market Product Insights

    The UK Real-Time PCR qPCR Market has been seeing a significant transformation, particularly within the Product segment, which is vital for the overall functioning and progression of the industry. In terms of market segmentation, the Product category consists of various components, including reagents and consumables, instruments, and software and services, each playing a crucial role in laboratory processes. Reagents and consumables are essential since they are fundamental to conducting PCR tests, representing a constant demand in both research and diagnostic applications across healthcare and pharmaceuticals.

    Their importance is underscored by their ubiquitous use in laboratories, hospitals, and even academic institutions, as they facilitate a wide range of genetic analyses. Instruments form another critical aspect of the Product segment; these include the sophisticated machines necessary for performing qPCR. The advancements in technology have led to newer models that not only improve accuracy and efficiency but also allow for higher throughput, enabling laboratories to meet the increasing demands for quick and reliable testing methods.

    The role of software and services cannot be overlooked; they are integral for managing data generated during qPCR analysis, ensuring the results are not only accurate but also compliant with regulatory standards.With an increasing focus on high-quality results and throughput, there is a growing emphasis on having comprehensive software solutions that support advanced data management and interpretation. Market statistics indicate that demand in the UK is being driven not only by advancements in these product areas but also by the rising prevalence of infectious diseases and the growing interest in genetic research.

    The interplay between innovation, increasing disease burden, and regulatory changes presents both challenges and opportunities for stakeholders within the UK Real-Time PCR qPCR Market, contributing further to the dynamics of market growth.The ongoing investments in healthcare infrastructure and research institutions are indicative of the UK's commitment to enhancing its capabilities in molecular diagnostics, thus influencing the future landscape of the Product segment significantly.

    Real-Time PCR qPCR Market Application Insights

    Real-Time PCR qPCR Market Application Insights

    The Application segment of the UK Real-Time PCR qPCR Market displays a diverse range of utilizations, prominently including Clinical, Research, and Forensics sectors. The Clinical applications are vital as they enhance diagnostics by enabling accurate detection of pathogens, thereby significantly improving patient outcomes and disease monitoring. In the realm of Research, qPCR plays a crucial role in gene expression analysis, genetic variation studies, and validating experimental results, making it fundamental for scientific advancement and innovation. The Forensics application contributes significantly to criminal investigations, facilitating the analysis of biological samples and ensuring justice through reliable DNA evidence.

    Collectively, these areas underscore the importance of Real-Time PCR qPCR technology in driving progress across healthcare, scientific inquiry, and law enforcement sectors, contributing to the overall growth dynamics of the UK market, supported by regulatory frameworks emphasizing rapid and accurate diagnostics and the need for high-quality research outputs. Therefore, the segmentation within the Real-Time PCR qPCR Market is not only valuable but essential for addressing the unique demands and challenges faced by these critical applications in the UK.

    Real-Time PCR qPCR Market End User Insights

    Real-Time PCR qPCR Market End User Insights

    The UK Real-Time PCR qPCR Market exhibits a diverse array of End Users that significantly contribute to its expansion. Hospitals and diagnostic centers are essential as they rely on accurate and timely testing for patient treatment, fueling demand for advanced PCR technologies. Research laboratories and academic institutes are key players, driving innovation and research, thereby enabling breakthroughs in molecular biology and genetics.

    Pharmaceutical and biotechnology companies leverage Real-Time PCR systems for drug development and quality control, positioning them at the forefront of advancements in healthcare.Clinical research organizations utilize these technologies to support clinical trials, ensuring compliance with regulatory standards while enhancing accuracy in data collection. Forensic laboratories utilize Real-Time PCR for DNA analysis, playing a crucial role in legal investigations.

    This segmented view illustrates the integral part each End User plays in the growth of the UK Real-Time PCR qPCR Market, highlighting their respective contributions toward advancing the market industry as well as driving innovative solutions across diverse applications.With increasing demand for precise diagnostics and research capabilities, opportunities for further growth in these segments remain robust.

    Get more detailed insights about UK Real Time PCR qPCR Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The UK Real-Time PCR qPCR Market has been witnessing significant growth, driven by advancements in molecular biology techniques and increased demand for rapid and accurate diagnostic tools. A mix of prominent players and emerging companies characterize the competitive landscape, each striving to leverage innovative technologies and offer a diverse portfolio of products and services to capture market share. This sector is influenced by various factors including regulatory changes, technological advancements, and the increasing prevalence of infectious diseases and genetic disorders, driving the need for effective diagnostic solutions.

    The competition is not only dictated by product offerings but also by strategic alliances, partnerships, and investment in research and development that enhance market presence in the UK.In the UK Real-Time PCR qPCR Market, Qiagen stands out with its robust product line and established reputation for high-quality solutions. The company has successfully positioned itself as a leader in molecular diagnostics and sample preparation technologies, facilitating advancements in research and clinical applications. Qiagen's strengths lie in its innovative assay development, comprehensive software solutions, and a user-friendly platform that resonates well with laboratories conducting real-time PCR analyses.

    The company's strategic focus on enhancing its product portfolio through continuous innovation and collaborations has fortified its presence in the UK market. By addressing the specific needs of stakeholders, including researchers and clinical laboratories, Qiagen has maintained a competitive edge, thereby securing significant market share in this rapidly evolving domain.PerkinElmer plays a crucial role in the UK Real-Time PCR qPCR Market with a focus on providing high-performance solutions for diagnostic testing and research applications. The company is known for developing key products such as genomic analysis tools, assay reagents, and detection instruments specifically designed for real-time PCR processes.

    This distinguishes PerkinElmer as a strong contender within the marketplace, bolstered by its commitment to advancing healthcare through science. Additionally, the company has engaged in strategic mergers and acquisitions to enhance its product offerings and expand its operational footprint in the UK, thereby increasing its competitiveness and market reach. PerkinElmer’s strengths lie in its innovative technologies, exceptional customer service, and a well-established network that supports a comprehensive suite of services, ensuring that the company effectively meets the growing demands in the real-time PCR sector across the UK.

    Key Companies in the UK Real Time PCR qPCR Market market include

    Industry Developments

    In the UK Real-Time PCR qPCR Market, several notable developments have emerged recently. In September 2023, Roche announced the launch of a new automated Real-Time PCR platform that has significantly enhanced testing capacities for various infectious diseases, thus improving laboratory efficiency and accuracy. Meanwhile, PerkinElmer reported an increase in demand for its qPCR solutions, particularly in genetic testing and COVID-19 monitoring, contributing to a notable growth in their revenue over the past year.

    Takara Bio has also invested heavily in expanding its product line, focusing on innovative reagents that promise improved sensitivity and specificity for various applications in the UK market. In terms of mergers and acquisitions, Thermo Fisher Scientific was reported to have acquired a UK-based biotechnology firm in July 2023 to enhance its portfolio and global reach, a move backed by financial analysts as a strategic growth initiative.

    This consolidation trend indicates a competitive landscape where major players like Qiagen, Merck KGaA, and BioRad Laboratories are poised to enhance their operational capacities in response to increasing market demands, particularly following the rise of personalized medicine and genomics over the past two years.

    Market Segmentation

    Outlook

    • Hospitals Centers
    • Research Laboratories Academic Institutes
    • Pharmaceutical Biotechnology Companies
    • Clinical Research Organizations
    • Forensic Laboratories

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 299.5(USD Million)
    MARKET SIZE 2024 350.0(USD Million)
    MARKET SIZE 2035 750.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.174% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Qiagen, PerkinElmer, Promega Corporation, SYGNIS AG, Takara Bio, Thermo Fisher Scientific, Roche, Merck KGaA, Danaher Corporation, Abbott Laboratories, Agilent Technologies, F. HoffmannLa Roche AG, BioRad Laboratories, Novo Nordisk, Illumina
    SEGMENTS COVERED Product, Application, End User
    KEY MARKET OPPORTUNITIES Increasing demand for diagnostics, Growth in personalized medicine, Expansion of research and development, Emergence of point-of-care testing, Rise in infectious disease testing
    KEY MARKET DYNAMICS Technological advancements in diagnostics, Increasing demand for personalized medicine, Rising prevalence of infectious diseases, Growing research funding and collaborations, Expanding applications in clinical laboratories
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the UK Real-Time PCR qPCR Market in 2024?

    The UK Real-Time PCR qPCR Market is expected to be valued at 350.0 million USD in 2024.

    What is the projected market size for the UK Real-Time PCR qPCR Market by 2035?

    By 2035, the overall market size is anticipated to reach 750.0 million USD.

    What is the expected CAGR for the UK Real-Time PCR qPCR Market from 2025 to 2035?

    The market is projected to grow at a CAGR of 7.174% from 2025 to 2035.

    What will be the market value of Reagents & Consumables in 2035?

    The market value for Reagents & Consumables is expected to be 307.5 million USD in 2035.

    What market size is projected for Instruments in the UK Real-Time PCR qPCR Market by 2035?

    In 2035, the projected market size for Instruments is estimated to be 270.0 million USD.

    Who are the key players in the UK Real-Time PCR qPCR Market?

    Major players include Qiagen, PerkinElmer, Promega Corporation, Thermo Fisher Scientific, and Roche.

    What is the expected market value of Software & Services in 2024?

    The market value for Software & Services is anticipated to be 80.0 million USD in 2024.

    What are the primary growth drivers of the UK Real-Time PCR qPCR Market?

    Key growth drivers include increasing demand for accurate diagnostics and advancements in technology.

    What impact does the current global scenario have on the UK Real-Time PCR qPCR Market?

    The global scenario impacts supply chains and research funding, influencing market conditions.

    What market growth rate can be expected for specific segments within the UK Real-Time PCR qPCR Market?

    Specific segments like Reagents & Consumables are expected to drive notable growth in market value.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Real-Time PCR qPCR Market, BY Product (USD Million)
    45. Reagents Consumables
    46. Instruments
    47. Software Services
    48. UK Real-Time PCR qPCR Market, BY Application (USD Million)
    49. Clinical
    50. Research
    51. Forensics
    52. UK Real-Time PCR qPCR Market, BY End User (USD Million)
    53. Hospitals Centers
    54. Research Laboratories Academic Institutes
    55. Pharmaceutical Biotechnology Companies
    56. Clinical Research Organizations
    57. Forensic Laboratories
    58. Competitive Landscape
    59. Overview
    60. Competitive Analysis
    61. Market share Analysis
    62. Major Growth Strategy in the Real-Time PCR qPCR Market
    63. Competitive Benchmarking
    64. Leading Players in Terms of Number of Developments in the Real-Time PCR qPCR Market
    65. Key developments and growth strategies
    66. New Product Launch/Service Deployment
    67. Merger Acquisitions
    68. Joint Ventures
    69. Major Players Financial Matrix
    70. Sales and Operating Income
    71. Major Players RD Expenditure. 2023
    72. Company Profiles
    73. Qiagen
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. PerkinElmer
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Promega Corporation
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. SYGNIS AG
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Takara Bio
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Thermo Fisher Scientific
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Roche
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Merck KGaA
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Danaher Corporation
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Abbott Laboratories
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Agilent Technologies
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. F. HoffmannLa Roche AG
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. BioRad Laboratories
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Novo Nordisk
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Illumina
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. References
    164. Related Reports
    165. UK Real-Time PCR qPCR Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    166. UK Real-Time PCR qPCR Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    167. UK Real-Time PCR qPCR Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    168. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    169. ACQUISITION/PARTNERSHIP
    170. MARKET SYNOPSIS
    171. UK REAL-TIME PCR QPCR MARKET ANALYSIS BY PRODUCT
    172. UK REAL-TIME PCR QPCR MARKET ANALYSIS BY APPLICATION
    173. UK REAL-TIME PCR QPCR MARKET ANALYSIS BY END USER
    174. KEY BUYING CRITERIA OF REAL-TIME PCR QPCR MARKET
    175. RESEARCH PROCESS OF MRFR
    176. DRO ANALYSIS OF REAL-TIME PCR QPCR MARKET
    177. DRIVERS IMPACT ANALYSIS: REAL-TIME PCR QPCR MARKET
    178. RESTRAINTS IMPACT ANALYSIS: REAL-TIME PCR QPCR MARKET
    179. SUPPLY / VALUE CHAIN: REAL-TIME PCR QPCR MARKET
    180. REAL-TIME PCR QPCR MARKET, BY PRODUCT, 2024 (% SHARE)
    181. REAL-TIME PCR QPCR MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    182. REAL-TIME PCR QPCR MARKET, BY APPLICATION, 2024 (% SHARE)
    183. REAL-TIME PCR QPCR MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    184. REAL-TIME PCR QPCR MARKET, BY END USER, 2024 (% SHARE)
    185. REAL-TIME PCR QPCR MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    186. BENCHMARKING OF MAJOR COMPETITORS

    UK Real-Time PCR qPCR Market Segmentation

    • Real-Time PCR qPCR Market By Product (USD Million, 2019-2035)

      • Reagents Consumables
      • Instruments
      • Software Services

    • Real-Time PCR qPCR Market By Application (USD Million, 2019-2035)

      • Clinical
      • Research
      • Forensics

    • Real-Time PCR qPCR Market By End User (USD Million, 2019-2035)

      • Hospitals Centers
      • Research Laboratories Academic Institutes
      • Pharmaceutical Biotechnology Companies
      • Clinical Research Organizations
      • Forensic Laboratories
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027